Baker Julian's Form 4 filing
Kodiak Sciences Inc. (KOD) · filed Jan 25, 2022
- Accession no.
- 0001209191-22-004852
- Filed
- Jan 25, 2022, 5:40 PM ET
- Trade date
- Jan 21-25, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 0 derivative transactions. Open-market purchases total $28.8M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baker JulianCIK 0001087939 | Director, 10% Owner |
| Baker FelixCIK 0001087940 | Director, 10% Owner |
| Baker Bros. Advisors LPCIK 0001263508 | Director, 10% Owner |
| Baker Brothers Life Sciences LPCIK 0001363364 | Director, 10% Owner |
| 667, L.P.CIK 0001551139 | Director, 10% Owner |
| Baker Bros. Advisors (GP) LLCCIK 0001580575 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2022 | Common Stock | PPurchaseAcquired | +102,207 | $56.57 | +$5,782,279.26 | 13,628,933 | Indirect | |
| Jan 21, 2022 | Common Stock | PPurchaseAcquired | +31,207 | $57.53 | +$1,795,291.9 | 13,660,140 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +19,750 | $56.39 | +$1,113,649.18 | 13,679,890 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +1,200 | $56.60 | +$67,914 | 13,681,090 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +116,083 | $56.87 | +$6,601,059.8 | 13,797,173 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +25,900 | $57.59 | +$1,491,518.84 | 13,823,073 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +132,367 | $58.13 | +$7,693,937.77 | 13,955,440 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +9,350 | $58.76 | +$549,367.67 | 13,964,790 | Indirect | |
| Jan 24, 2022 | Common Stock | PPurchaseAcquired | +57,547 | $58.87 | +$3,387,843.68 | 14,022,337 | Indirect | |
| Jan 25, 2022 | Common Stock | PPurchaseAcquired | +5,500 | $58.90 | +$323,934.05 | 14,027,837 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.